TWEAK receptor
AssigneeImmunex Corporation
InventorSteven R. Wiley
Life of this patent
Estimating the term…
Abstract
The present invention provides the TWEAK receptor and methods for identifying and using agonists and antagonists of the TWEAK receptor. In particular, the invention provides methods of screening for agonists and antagonists and for treating diseases or conditions mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue.
Claims10
An isolated polypeptide consisting of a sequence of amino acids that is at least 80% identical to a reference sequence of amino acids, wherein said reference sequence of amino acids consists of residue 28 to residue x1 of SEQ ID NO:4, x1 is selected from the group of residues 68 to 80 of SEQ ID NO:4, and said isolated polypeptide binds to TWEAK.
An isolated polypeptide comprising a sequence Z1-X-Z2, wherein Z1 and Z2 each individually is a polypeptide consisting of a sequence of amino acids that is at least 80% identical to a reference sequence of amino acids, wherein said reference sequence of amino acids consists of residue 28 to residue x1 of SEQ ID NO:4, x1 is selected from the group of residues 68 to 80 of SEQ ID NO:4, X is a peptide linker, and said isolated polypeptide binds to TWEAK.
Dependencies are inferred from the claim text.